Concepedia

Catherine Brisbare‐Roch

CB

Statistics

Publications

10

Citations

849

H-Index

10

Active since

2007

Affiliations

Actelion (Switzerland)(Current)

Catherine Brisbare‐Roch is an author at Actelion (Switzerland) specializing in orexin pharmacology, pharmacology, and orexin signaling.

Publications per year

2007–2014

10

Publications

10

Promotion of sleep by targeting the orexin system in rats, dogs and humans

Catherine Brisbare‐Roch, Jasper Dingemanse, Ralf Koberstein et al. · Nature Medicine · 2007 · 567 citations

, , +12

Discovery and Characterization of ACT‐335827, an Orally Available, Brain Penetrant Orexin Receptor Type 1 Selective Antagonist

Michel A. Steiner, John Gatfield, Catherine Brisbare‐Roch et al. · ChemMedChem · 2013 · 95 citations

, , +17

Differential Effects of the Dual Orexin Receptor Antagonist Almorexant and the GABAA-α1 Receptor Modulator Zolpidem, Alone or Combined with Ethanol, on Motor Performance in the Rat

Michel A. Steiner, Hugues Lecourt, Daniel S. Strasser et al. · Neuropsychopharmacology · 2010 · 48 citations

, , +17

N-Glycine-sulfonamides as potent dual orexin 1/orexin 2 receptor antagonists

Hamed Aissaoui, Ralf Koberstein, Cornelia Zumbrunn et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 28 citations · Full text

, , +9

Orexin Receptor Antagonism: A New Principle in Neuroscience

Christoph Boss, Catherine Brisbare‐Roch, François Jenck et al. · CHIMIA International Journal for Chemistry · 2008 · 27 citations · Full text

, , +17

1–5 of 10